mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |